- Home
- Products
- Customized ADCs
- CD22
- Anti-CD22-Mc-VC-PAB-NMS249 ADC
Anti-CD22-Mc-VC-PAB-NMS249 ADC (CAT#: ADC-W-540)
This ADC product is comprised of an anti-CD22 monoclonal antibody (clone C16) conjugated via a Mc-VC-PAB linker to NMS249.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CD22
- Alternative Names
- CD22; CD22 molecule; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2;
- Target Entrez Gene ID
- 933
- Target UniProt ID
- P20273
- Overview
- CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases. CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.
- Overview
- Anti-CD22 Antibody
- Species Reactivity
- Human
- Name
- mc-VC-PAB (proteaselabile maleimido-caproyl-valine-citrulline-para-amino-benzyloxy carbonyl )
- Description
- Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Name
- NMS249
- Description
- Anthracyclines (or anthracycline antibiotics) are a class of drugs (CCNS or cell-cycle non-specific) used in cancer chemotherapy derived from Streptomyces bacterium Streptomyces peucetius var. caesius.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CSF1R (Emactuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2453)
- Anti-CD33 (clone m2H12)-Mc-MMAF ADC (CAT#: ADC-W-114)
- Anti-ITGB3 (Tadocizumab)-SPDB-DM4 ADC (CAT#: ADC-W-2605)
- Anti-IgE Fc (Talizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2153)
- Anti-C. diff Toxin A (Actoxumab)-MC-MMAF ADC (CAT#: ADC-W-2050)
- Anti-CD70 (clone h1F6)-β-glucuronide-MMAF ADC (CAT#: ADC-W-375)
- Anti-CD27 (Varlilumab)-SPDB-DM4 ADC (CAT#: ADC-W-2223)
- Anti-IL6 (Olokizumab)-SPDB-DM4 ADC (CAT#: ADC-W-1419)
- Anti-IL13 (Tralokinumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1296)
- Anti-IL12+IL23 (Briakinumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2027)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-540. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
CAT# | Product Name | Linker | Payload |
ADC-W-461 | Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC | AcBut (4-(4-acetylphenoxy)butanoic acid) | CalichDMH |
ADC-W-2524 | Anti-CD22 (Inotuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
ADC-W-2536 | Anti-CD22 (Pinatuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-2528 | Anti-CD22-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
ADC-W-484 | Anti-CD22 (clone hu10F4)-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.